Said Alsidawi is a Cardiology physician affiliated with Twitter. OpenAlex indexes 166 publications with 826 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
13400 E Shea Blvd
Scottsdale, AZ 852595452
Telephone
480-301-8000Provider last certified this registry record 1 Dec 2022.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20256 payments
- Edwards Lifesciences CorporationProgram year20251 payment
- BioMarin Pharmaceutical Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
72.2%Beta blocker20%Metoprolol Succinate42%Carvedilol25%Metoprolol Tartrate18%Atenolol9%Bisoprolol Fumarate6%Part D<11 patientsStatin13.1%Atorvastatin Calcium52%Rosuvastatin Calcium35%Pravastatin Sodium13%Part D<11 patients+ 11 more classes in this area
Blood & clotting
15.9%Factor Xa inhibitor12.9%Eliquis83%Xarelto17%Part D<11 patientsVitamin K antagonist1.6%Warfarin Sodium100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
8.4%SGLT2 inhibitor6.7%Jardiance85%Farxiga15%Part D<11 patientsPotassium supplement1.7%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Echocardiographic Changes With Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy
Journal of the American College of Cardiology
2025 - Elevated lipoprotein(a) levels linked to new-onset atrial fibrillation: insights from a retrospective cohort study
European Journal of Preventive Cardiology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Kousik Krishnan, MD
Thomas Frieden, MD
Lakhbir Sandhu, MD, PhD, FRCSC
Mary Strek
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”